Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-11 | 2024-09 | -0.05 | N/A | N/A | N/A |
2024-08-12 | 2024-06 | -0.05 | -0.05 | N/A | N/A |
2024-05-13 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-04-01 | 2023-12 | -0.05 | -0.06 | -0.01 | -20.00% |
2023-11-13 | 2023-09 | 0 | -0.05 | N/A | N/A |
2023-08-14 | 2023-06 | 0 | -0.06 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-07 | Cantor Fitzgerald | Upgrade | Overweight | |
2020-09-16 | Ascendiant Capital | Upgrade | Buy | |
2019-12-17 | Maxim Group | Upgrade | Hold | Buy |
2018-01-25 | Maxim Group | Upgrade | Buy | |
2013-10-06 | Sidoti & Co. | Downgrade | Buy | Neutral |
2013-04-14 | Sidoti & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2016-03-08 | CHEN SHU-CHIH | Director and Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2013-05-14 | CROSS ALEXANDER DENNIS | Director | 0.00 | Purchase |
2024-04-09 | FINN JONATHAN F. | Director | 25.00K | Purchase |
2017-11-14 | GUSE KYLE | General Counsel | 10.00K | Purchase |
2016-03-08 | QUAY STEVEN C | Chief Executive Officer | 0.00 | Purchase |
2017-04-16 | REMMEL H LAWRENCE | Director | 3.13K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 5.68M | 7.15M | 4.51% |
2023-06-29 | Blackrock Inc. | 2.90M | 3.65M | 2.30% |
2023-06-29 | Laurion Capital Management, LP | 2.23M | 2.80M | 1.77% |
2023-06-29 | Geode Capital Management, LLC | 1.11M | 1.40M | 0.88% |
2023-06-29 | Renaissance Technologies, LLC | 1.07M | 1.35M | 0.85% |
2023-06-29 | State Street Corporation | 436.27K | 549.70K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.78M | 4.76M | 3.00% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.66M | 2.10M | 1.32% |
2023-05-30 | Fidelity Extended Market Index Fund | 659.95K | 613.75K | 0.52% |
2023-05-30 | BlackRock Advantage Small Cap Core Fund | 340.50K | 316.67K | 0.27% |
2023-05-30 | Fidelity Total Market Index Fund | 182.91K | 170.11K | 0.15% |
2023-05-30 | Fidelity Series Total Market Index Fund | 142.17K | 132.22K | 0.11% |
Split | Date |
---|---|
1 : 12 | 2018-04-20 |
1 : 15 | 2016-08-26 |
-
Yup that works for me shkspr will you send email to get a hold of you?
-
Shkspr im interested, how do i get a hold of you?
-
Just popped in to see if these delusional are still expecting Quay to deliver lol. He took yalls money in Dec 2021 and it’s been a crap show ever since. Cut your losses and move on, this will never recover.
-
Just added more, just over 25,000 @1.12 whoot whoot
-
Wow you guys make it too easy for the shorts
-
Offering on the horizon….
-
30$ will give me 800,000usd
-
30$ will give me 800,000usd
-
I see Quay still has some stubborn ones supporting him lol. Y’all deserve to lose every penny if you are this dense.
-
We do not know what is next with this market.. but this stock can soar overnight.. watch everyone
-
Once we see the run…don’t miss out
-
Why is this getting pummeled today?
-
Boy the sentiment for this has reached the bottom of the barrel. Now relegated to praying that AZN will do a hostile takeover. Lmmfao. At what point do you finally admit Quay has destroyed this company? When it hits .80 next week? When it hits .30 by summer?
-
Quay wants the shares so he can get one final payday. The company has nothing promising. Endoxofin has been around for damn near ten years now, in various testing phases. It’s not going to amount to anything. Look at the cancelled shareholder vote last year, and look at the vote that got shot down. All he had to do was produce ANYTHING remotely optimistic and he would have secured $1 billion in funding. He couldn’t produce anything to secure it. Even the institutional investors voted NO.
This will only have value once it drops under $1, and then only for the Options.
He has effectively killed this company.
-
Sold at $3.75 and said I’d re-enter if it dropped under a buck. Looks like it’s getting closer and closer.
Quay has completely obliterated this company.
-
Has Quay named his yacht yet?
Get ready to go under $1.
Told y’all this was dead in September.
-
Thank a Democrat.
-
Yah Quay!!!!!
-
Tried to tell y’all to get out at 3.85.
-
Atos: contract to reinforce a supercomputer in Sweden
news.google.com • -
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
globenewswire.com • -
3 Dirt-Cheap Drug Developers With Blockbuster Potential
investorplace.com • -
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025
investorplace.com • -
Atossa Therapeutics names Heather Rees as CFO
proactiveinvestors.com • -
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer
globenewswire.com • -
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
globenewswire.com • -
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
investorplace.com • -
Atossa to Present at the Sidoti Small-Cap Investor Conference
globenewswire.com •